Log In
BCIQ
Print this Print this
 

PF-06647020

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionAntibody-drug conjugate (ADC) composed of humanized anti-PTK7 protein tyrosine kinase 7 (PTK7; CCK4) antibody linked to an auristatin
Molecular Target PTK7 protein tyrosine kinase 7 (PTK7) (CCK4)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today